Mangogna, A.; Munari, G.; Pepe, F.; Maffii, E.; Giampaolino, P.; Ricci, G.; Fassan, M.; Malapelle, U.; Biffi, S.
Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches. J. Pers. Med. 2023, 13, 284.
https://doi.org/10.3390/jpm13020284
AMA Style
Mangogna A, Munari G, Pepe F, Maffii E, Giampaolino P, Ricci G, Fassan M, Malapelle U, Biffi S.
Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches. Journal of Personalized Medicine. 2023; 13(2):284.
https://doi.org/10.3390/jpm13020284
Chicago/Turabian Style
Mangogna, Alessandro, Giada Munari, Francesco Pepe, Edoardo Maffii, Pierluigi Giampaolino, Giuseppe Ricci, Matteo Fassan, Umberto Malapelle, and Stefania Biffi.
2023. "Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches" Journal of Personalized Medicine 13, no. 2: 284.
https://doi.org/10.3390/jpm13020284
APA Style
Mangogna, A., Munari, G., Pepe, F., Maffii, E., Giampaolino, P., Ricci, G., Fassan, M., Malapelle, U., & Biffi, S.
(2023). Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches. Journal of Personalized Medicine, 13(2), 284.
https://doi.org/10.3390/jpm13020284